FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), Customizable Glucose
Select See the table below
- See the table below
FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), Customizable Glucose
Dulbecco's Modified Eagle Medium (DMEM) is one of the most widely used modifications of Eagle's medium. DMEM is a modification of Basal Medium Eagle (BME) that contains four-fold concentrations of amino acids and vitamins. The formulation also includes glycine, serine, and ferric nitrate. The original formulation contains 1 g/L of glucose and was originally used to culture embryonic mouse cells. Because different cell types and experimental conditions call for different energy inputs, FluxMPS™ DMEM is offered with a fully customizable glucose concentration, purified through the same FluxMPS™ quadruple-stage 0.04 micron filtration used across every DMEM variant.
- Glucose concentration is fully customizable to match your cell type and experimental design
- Default options available: High Glucose (4.5 g/L), Low Glucose (1.0 g/L), and no-Glucose medium
- Rich nutrient profile: Includes 15 amino acids — Eagle’s essential set plus glycine and L-serine — and 8 water-soluble vitamins at approximately 4x the Basal Medium Eagle (BME) level.
- Flexible buffering options: sodium bicarbonate buffer system that helps maintain physiological pH in a 5–10% CO2 incubator, with 25 mM HEPES variants also available.
- FluxMPS™ quadruple-stage 0.04 micron filtration — finer than any ready-to-use cell culture media currently available
- Validated across NIH/3T3, HEK293/HEK293T, COS-7, RAW 264.7, HeLa, and primary mouse embryonic cell workflows
- Ships in 500 mL and 1000 mL bottles. Stored at 2–8 °C away from bright light. Custom pH, glucose concentration, salts, HEPES level, and added supplements available on request — please contact support@diagnocine.com.
- Concentration1X
- GlucoseConfigurable (+/-)
- L-Glutamine / Sodium PyruvateConfigurable (+/-)
- Sodium Bicarbonate / HEPESConfigurable (+/-)
- Phenol RedConfigurable (+/-)
- Salt baseNaCl, KCl, CaCl2, MgSO4, NaH2PO4, +Fe(NO3)3
- BufferingCO2-dependent, Bicarbonate, and/or 25 mM HEPES
- Sizes500 mL, 1000 mL
- Storage2–8°C, away from bright light
Why Glucose Concentration Matters
Different glucose concentrations are used to meet the varying energy requirements of different cell types and experimental conditions. Here are some reasons why researchers might want to use DMEM with different glucose sizes (concentrations):
- Cell type-specific energy demands: Different cell types have varying metabolic rates and energy requirements.
- Mimicking physiological conditions: Normal glucose levels in human blood range from 4-7 mM. To mimic physiological conditions, researchers may use DMEM with 5-6 mM glucose for culturing certain cell types like primary cells or stem cells.
- Hypoxia or ischemia studies: In hypoxic or ischemic conditions, cells experience low oxygen levels and rely more on glycolysis for energy production. Using DMEM with higher glucose (e.g., 25 mM) can help maintain cell viability and function under these conditions.
- Differentiation studies: The glucose concentration can influence the differentiation potential of certain stem cells or progenitor cells. For example, lower glucose levels (5 mM) may promote neuronal differentiation, while higher levels (25 mM) may favor adipogenic differentiation.
- Metabolic studies: Researchers investigating cellular metabolism, glycolysis, or the Warburg effect (increased glycolysis in cancer cells) may use DMEM with varying glucose concentrations to study the metabolic responses and adaptations of cells.
Optimize Your Cell Culture with DMEM's Versatile Glucose Options
By default, we offer High Glucose (4.5 g/L), Low Glucose (1.0 g/L), and no-Glucose medium.
About DMEM, Customizable Glucose
Dulbecco's Modified Eagle Medium (DMEM) is one of the most widely used modifications of Eagle's medium. DMEM is a modification of Basal Medium Eagle (BME) that contains four-fold concentrations of amino acids and vitamins. The formulation also includes glycine, serine, and ferric nitrate. The original formulation contained 1000 mg/L glucose and was originally used to culture embryonic mouse cells.
DMEM is an enriched derivative of Basal Medium Eagle (BME) and is one of the most widely used basal media in cell culture, originally developed to support mouse embryonic cells and now a default choice for high-density and fast-growing adherent cultures. It contains roughly fourfold higher concentrations of amino acids and vitamins than the original BME formulation, along with elevated glucose and an added trace iron source, making it well-suited to metabolically demanding cell culture applications.
Origins and Development
DMEM traces directly to Harry Eagle's foundational work at the National Institutes of Health, where his 1955 studies defined the minimal nutritional requirements of HeLa and L (L929) cells and led to the development of Basal Medium Eagle later noted that BME emerged from systematic nutritional studies rather than from a planned attempt to design a culture medium. In 1959, Eagle expanded BME into Minimum Essential Medium (MEM) by increasing amino acid concentrations to extend culture maintenance and broaden the range of supported cell lines.
That same year, Renato Dulbecco and G. Freeman introduced their own modification of Eagle's medium in a footnote in their Virology paper on plaque production by the polyoma virus (Virology 8: 396–397, 1959). The modification — now universally known as Dulbecco's Modified Eagle Medium (DMEM, or DME) — had substantially higher concentrations of amino acids and vitamins than BME and was used to support the culture of mouse embryonic cells in monolayers needed for quantitative virus plaque assays. As with Eagle's original work, the medium emerged as a practical tool in service of a virological objective rather than as a standalone engineering goal, and it likewise depended on serum supplementation to support proliferation.
In the decade that followed, the formulation was adapted and commercialized in several variants. Higher-glucose versions (4.5 g/L) were developed to support rapidly proliferating and transformed cell lines, and DMEM was extended to primary cultures of mouse and chicken cells, as well as a broad spectrum of normal and transformed cell types. Surveys of commercial media from this period (Morton, 1970) document how DMEM diversified into the family of glucose-, pyruvate-, glutamine-, and buffer-variant media still in use today.
Note on parent formulation: Multiple authoritative sources — including the Cantor 2019 Trends in Cell Biology review, Sigma-Aldrich, and Corning — classify DMEM as a derivative of BME. Some commercial literature describes the four-fold enrichment relative to "Eagle's Minimal Essential Medium"; the Dulbecco footnote itself refers simply to "Eagle's medium." The scientific consensus, anchored by primary review literature, identifies BME as the direct parent.
The DMEM Family Tree
DMEM sits in the middle of a lineage that begins with Eagle and continues into several enriched descendants:
- BME (1955, Eagle) — the parent formulation; a basal amino acid and vitamin mix, including glutamine, biotin, and baseline inorganic salts.
- MEM (1959, Eagle) — a BME derivative with increased amino acid concentrations; biotin was omitted after Eagle found it dispensable.
- DMEM (1959, Dulbecco & Freeman) — a further-enriched BME modification (approximately 4x amino acids and vitamins vs. BME) with 15 amino acids (adding glycine and L-serine to the Eagle essential set) and added ferric nitrate, originally for mouse embryonic cells and viral plaque assays.
- DMEM/F-12 — a 1:1 mixture of high-glucose DMEM and Ham's F-12, combining DMEM's rich amino acid/vitamin profile with F-12's trace elements and lipids for lower-serum and serum-free work.
- IMDM (Iscove's Modified Dulbecco's Medium, 1978; Iscove & Melchers) — an enriched DMEM derivative adding selenium, additional amino acids and vitamins, sodium pyruvate, HEPES buffer, and potassium nitrate in place of ferric nitrate; designed for high-density, rapidly proliferating cultures such as lymphocytes and hematopoietic cells.
In parallel, the broader Eagle lineage also gave rise to RPMI 1640, developed by Moore, Gerner, and Franklin at Roswell Park Memorial Institute (1966; published in JAMA 199: 519-524, 1967). RPMI 1640's direct parent is McCoy's 5A Modified Medium, which was itself based in part on BME — illustrating how a single nutritional framework branched into the modern catalog of classical media.
DMEM Composition
Categorical composition summary as documented in the source formulation record. Per-lot Certificate of Analysis (CoA) requests can be directed to support@diagnocine.com.
| Component | Description |
|---|---|
| Amino acids | 15 amino acids — Eagle's essential set plus glycine and L-serine; concentrations approximately 4x BME baseline. |
| Vitamins | 8 water-soluble vitamins at approximately 4x BME baseline: choline chloride, folic acid, myo-inositol, niacinamide, D-calcium pantothenate, pyridoxine HCl (in the dominant Gibco/Thermo Fisher formulation; some suppliers substitute pyridoxal HCl), riboflavin, thiamine HCl. Biotin and vitamin B12 are absent. |
| Inorganic salts | NaCl, KCl, CaCl2, MgSO4, NaH2PO4, NaHCO3, plus ferric nitrate [Fe(NO3)3 * 9H2O] as a distinctive trace-iron source (0.1 mg/L). |
| Glucose | 1.0 g/L (5.5 mM) in the original low-glucose formulation; 4.5 g/L (25 mM) in the common high-glucose variant. Fully customizable to other concentrations, including glucose-free, on request. |
| Sodium pyruvate | Approximately 110 mg/L (1 mM) included in many formulations (variant-dependent). |
| Serum requirement | Not a complete medium; typically 10% FBS (5-20% depending on cell line). |
| pH buffering | Bicarbonate-based (approximately 3.7 g/L NaHCO3), CO2-dependent (5-10% CO2); phenol red as pH indicator. |
| pH / osmolality | 7.4 ± 0.04; typically 320-370 mOsm/kg depending on formulation and manufacturer. |
Media Lineage Comparison: BME vs. MEM vs. DMEM
Categorical comparison of DMEM against its direct ancestors in the Eagle lineage.
| Feature | BME | MEM | DMEM (FluxMPS™ family) |
|---|---|---|---|
| Amino acid level | Baseline — minimal | ~2× BME | ~4× BME |
| Vitamin level | Baseline, includes Biotin | Often lacks Biotin | 4× BME |
| Glucose | 1.0 g/L | 1.0 g/L | Glucose-FREE |
| Added iron source | None | None | Ferric nitrate, 0.1 mg/L |
| Serum supplement | 5-10% recommended | 5-10% recommended | 10–20% typical |
| pH buffering | Bicarbonate, CO2-dependent | Bicarbonate, CO2-dependent | Bicarbonate, 5-10% CO2 (or HEPES) |
| Developer & year | Harry Eagle, 1955 | Harry Eagle, 1959 | Dulbecco & Freeman, 1959 |
Why FluxMPS™ DMEM, Customizable Glucose
Quadruple-Stage 0.04 Micron Filtration
Purified to 0.04 microns — finer than any ready-to-use cell culture media currently available — removing the microscopic particulates and protein aggregates that silently block micro-channels.
Built for OoC / ToC / LoC Platforms
Engineered from the ground up for Organ-on-Chip, Tissue-on-Chip, and Lab-on-Chip platforms, where the medium itself is part of the instrument and cannot be an afterthought.
Particulate & Aggregate Removal
Eliminates particulates and protein aggregates that disrupt laminar flow and generate false biological signals before the media ever reaches the chip.
Optical Clarity
Supports real-time imaging and integrated biosensing on Organ-on-Chip platforms, where optical clarity of the medium is essential to data quality.
FDA-Recognized Physiological Modeling Standards
Formulated to support FDA-recognized physiological modeling standards, providing a validated, reproducible media foundation for regulatory-facing studies.
Drug Discovery, Toxicology & Translational Research
A validated foundation for drug discovery, toxicology screening, and translational research, where downstream data must stand up to regulatory scrutiny.
Quadruple-Stage Filtration System
Every FluxMPS™ DMEM, Customizable Glucose variant passes through the same four-stage architecture before reaching your chip.
-
01
Pre-Filtration Stage 1 0.1 µm
Initial coarse particulate removal.
-
02
Pre-Filtration Stage 2 0.1 µm
Secondary particulate and aggregate reduction.
-
03
Sterile Filtration Stage 1 0.04 µm
Fine sterile filtration below standard 0.22 micron practice.
-
04
Sterile Filtration Stage 2 0.04 µm
Final polish for microfluidic-grade clarity.
Engineered for Flow, Not Just Growth
Every component is optimized for consistent, laminar flow performance across complex micro-channel geometries, capillary-bed and vascular simulations, and long-term automated perfusion studies running continuously for weeks.
Validated Cell Lines & Applications
DMEM is the standard or recommended medium across a wide range of cell types, including:
Primary Mouse Embryonic Cells / MEFs
DMEM's original application; also extended early on to primary mouse and chicken cultures.
NIH/3T3 Mouse Fibroblasts
A classic immortalized adherent line routinely maintained in DMEM.
HEK293 / HEK293T
The workhorse lines for transient transfection and recombinant protein and viral-vector production, typically in high-glucose DMEM.
COS-7
SV40-transformed African green monkey kidney cells used for transient expression.
RAW 264.7 Mouse Macrophages
Routinely maintained in DMEM for macrophage-based cell culture studies.
HeLa & Other Transformed Epithelial Lines
Broadly supported in DMEM as well as in other Eagle-family media.
Scientific Applications
Transfection & Viral-Vector Production
High-glucose DMEM is the default medium for HEK293/293T-based workflows — transient transfection, recombinant protein expression, and lentivirus/AAV packaging — where elevated glucose and amino acid content sustain the high metabolic demand of rapidly dividing producer cells.
General Adherent & High-Density Culture
Because DMEM provides nutrients well above the minimal Eagle baseline, it supports fast proliferation of fibroblasts and many transformed adherent lines, making it the routine maintenance medium across much of mammalian cell culture.
Physiologic Media Comparison Studies
DMEM is the canonical example of a "traditional" medium whose nutrient levels diverge sharply from human plasma — notably its supraphysiologic glucose (25 mM in the high-glucose formulation) and amino acid concentrations. For this reason, DMEM (alongside RPMI 1640) serves as the principal comparator in the physiologic-media literature (e.g., the Cantor 2019 review), where plasma-like formulations such as HPLM and Plasmax are benchmarked against it to show how conventional media reshape cell metabolism.
Frequently Asked Questions
Verified Bibliography
- Dulbecco, R. & Freeman, G. (1959). Plaque production by the polyoma virus. Virology, 8(3), 396-397. PMID: 13669362
- Smith, J.D., Freeman, G., Vogt, M. & Dulbecco, R. (1960). The nucleic acid of polyoma virus. Virology, 12(2), 185-196.
- Eagle, H. (1955). Nutrition Needs of Mammalian Cells in Tissue Culture. Science, 122(3168), 501-504. PMID: 13255879
- Eagle, H. (1959). Amino Acid Metabolism in Mammalian Cell Cultures. Science, 130(3373), 432-437. PMID: 13658943
- Morton, H.J. (1970). A Survey of Commercially Available Tissue Culture Media. In Vitro, 6(2), 89-108. PMID: 5523183
- Iscove, N.N. & Melchers, F. (1978). Complete replacement of serum by albumin, transferrin, and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes. J. Exp. Med., 147(3), 923-933. PMID: 305462
- Moore, G.E., Gerner, R.E. & Franklin, H.A. (1967). Culture of normal human leukocytes. JAMA, 199(8), 519-524.
- Cantor, J.R. (2019). The Rise of Physiologic Media. Trends in Cell Biology, 29(11), 854-861. PMC7001851
- Yao, T. & Asayama, Y. (2017). Animal-cell culture media: History, characteristics, and current issues. Reproductive Medicine and Biology, 16(2), 99-117. PMC5661806
FluxMPS™ — Precision Cell Culture Media for Microphysiological Systems
Built for the architecture of the future. Not the flask of the past.
Traditional cell culture media were formulated for static well plates and flasks — environments that tolerate impurities, precipitates, and particle loads that would immediately compromise a microfluidic system. FluxMPS™ was designed from the ground up for Organ-on-Chip (OoC), Tissue-on-Chip (ToC), and Lab-on-Chip (LoC) platforms, where the medium itself is part of the instrument.
Purity That Protects Your Platform
FluxMPS™ is purified to 0.04 microns — finer than any ready-to-use cell culture media currently available. At this level, the microscopic particulates and protein aggregates that silently block micro-channels, disrupt laminar flow, and generate false biological signals are eliminated before the media ever reaches your chip.
The result: your platform stays operational, your data stays clean, and your biology drives the result — not your media.
Engineered for Flow, Not Just Growth
The name FluxMPS™ reflects its core design principle. Every component is optimized for consistent, laminar flow performance across:
- Complex micro-channel geometries
- Capillary-bed and vascular simulations
- Long-term automated perfusion studies running continuously for weeks
Zero-clogging performance is not a feature — it is the baseline specification.
Applications & Performance
| Application | What FluxMPS™ Delivers |
|---|---|
| Microfluidics | Stable shear stress; no channel blockage |
| Metabolic Tracing | Ultra-pure matrix with no contaminant interference |
| Long-term Perfusion | Consistent formulation stability over weeks of continuous flow |
| Organ-on-Chip | Optical clarity for real-time imaging and integrated biosensing |
Regulatory Foundation
FluxMPS™ is formulated to support FDA-recognized physiological modeling standards, providing a validated, reproducible media foundation for drug discovery, toxicology screening, and translational research. When your downstream data needs to stand up to regulatory scrutiny, your upstream media cannot be an afterthought.
The Bottom Line
Microfluidic platforms are precision instruments. They require precision inputs.
FluxMPS™ is the only ready-to-use cell culture medium engineered specifically to meet that standard — protecting your chip, your cells, and your science.
